Physician profile
Benjamin Perrin
NPI 1245763614
$10,894.12
in general payments reported to CMS, 2019-2025
35 companies · $2,880 in 2025
The $2,880 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $783 · 2022: $2,394 · 2023: $2,497 · 2024: $2,340 · 2025: $2,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,204 · Consulting Fee: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,203.99 |
| Consulting Fee | $513.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,379.35 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,203.03 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $1,146.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,079.52 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $759.17 | 2021-2025 | Repatha, Otezla, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $755.28 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $754.94 | 2021-2025 | |
| Glaxosmithkline, LLC. | $727.96 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $374.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $350.84 | 2022-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $343.10 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $333.09 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $205.28 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $202.69 | 2021-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Biohaven Pharmaceutical Holding Company LTD. | $199.42 | 2022 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Perrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.